| Market Capitalization (Millions $) |
889 |
| Shares
Outstanding (Millions) |
49 |
| Employees |
1,115 |
| Revenues (TTM) (Millions $) |
314 |
| Net Income (TTM) (Millions $) |
-20 |
| Cash Flow (TTM) (Millions $) |
-39 |
| Capital Exp. (TTM) (Millions $) |
23 |
Staar Surgical Co
Staar Surgical Co. is a California-based medical technology company that specializes in developing, manufacturing, and marketing implantable lenses to treat cataracts, refractive errors, and presbyopia. The company was founded in 1982 and has since grown to become a global leader in ophthalmic surgical products, with operations in over 75 countries worldwide.
Staar Surgical's flagship product is the Visian implantable Collamer lens (ICL), which is used to correct nearsightedness, farsightedness, and astigmatism. The ICL is a small, flexible lens that is surgically implanted behind the pupil and in front of the natural lens of the eye. The lens is made of a biocompatible material called collamer that does not cause an immune response and has been found to be safe and effective in over 1 million procedures worldwide.
In addition to the ICL, Staar Surgical sells a range of other ophthalmic surgical products, including intraocular lenses (IOLs), phacoemulsification systems, and micro-invasive glaucoma surgery (MIGS) devices. The company also recently launched a new product called Evo Viva, a next-generation ICL that incorporates advanced optic designs to enhance visual quality and reduce glare and halos.
Staar Surgical has a strong track record of innovation and research, with over 75 patents and patent applications in the United States and internationally. The company has also invested heavily in clinical trials to demonstrate the safety and effectiveness of its products, with more than 20 major clinical studies conducted to date.
Overall, Staar Surgical Co. is a leading player in the global ophthalmic surgical market, with a strong focus on developing innovative and effective treatment options for a wide range of vision conditions. The company is committed to improving patient outcomes through advanced technology and clinical research, and is well-positioned for continued growth and success in the years ahead.
Company Address: 25510 Commercentre Drive Lake Forest 92630 CA
Company Phone Number: 303-7902 Stock Exchange / Ticker: NASDAQ STAA
|
8.91% 
94.48 %